Fundrise

Washington, D.C., U.S.  All United States companies → Founded 2010
Emergency Medicine Family Medicine Internal Medicine
Series A (for some funding rounds, but also has raised debt and operates an IPO model for its own company) — $53.7M - $1.49B (reported ranges, with additional credit facilities)

Products

Fundrise
Fundrise
Physician Finance & Tax
Fundrise allows physicians to passively invest in diversified private real estate portfolios with a low minimum investment, offering an alternative for wealth building and portfolio diversification.

See all 1 product →

About Fundrise

Fundrise is a financial technology company that operates an online investment platform, primarily focused on democratizing access to private market investments for individual investors. While not a healthcare AI company, Fundrise leverages technology, including AI, within its operations to enhance efficiency and investor experience. For instance, they utilize AI in customer service, achieving a high resolution rate for inquiries, and are developing a ‘RealAI’ platform to apply AI capabilities to real estate underwriting and operations.

The company’s core business revolves around offering various proprietary funds, including real estate private equity, private credit, and venture capital. Their offerings aim to provide individual investors, including non-accredited investors, access to asset classes traditionally reserved for institutional investors, with a focus on low fees and transparency. Fundrise manages a multi-billion dollar portfolio of private market assets, with a significant portion invested in real estate across the United States. They have also expanded into venture capital through their Innovation Fund (VCX), which invests in leading private technology and AI companies like OpenAI and Anthropic.

For physicians looking to diversify their investment portfolios beyond traditional public markets, Fundrise offers a pathway to private assets. The platform’s use of technology aims to simplify the investment process and reduce costs associated with private market access. Physicians interested in real estate can explore Fundrise’s eREITs and eFunds, which invest in various property types such as build-for-rent residential housing, multifamily units, and industrial assets, particularly in the Sunbelt region. For those with an interest in the technology sector, the Fundrise Innovation Fund provides exposure to high-growth private tech companies, including those at the forefront of AI and machine learning.

Focus Areas

Real estate (private equity private credit) Venture Capital (private technology companies AI/ML fintech modern data infrastructure)

What Physicians Need to Know

Real Estate Specialization
Fundrise is one of the largest real estate private equity investors globally, deploying over $1 billion annually in 2021 and 2022. Their portfolio primarily consists of 20,000+ residential units and eCommerce-centric industrial assets. They focus on long-term macroeconomic drivers like Sunbelt housing and e-commerce logistics. Fundrise offers various real estate strategies including Fixed Income, Core Plus, Value-Add, and Opportunistic, with investments in build-for-rent housing, multifamily, and industrial properties in high-growth markets like the Sunbelt.
Private Credit Specialization
Fundrise's private credit strategy capitalizes on market shifts and rising interest rates to target attractive risk-adjusted returns. They provide financing in the form of preferred equity and debt for real estate developments, particularly in Sunbelt markets. Their Opportunistic Credit Fund focuses on high-yield, real estate-backed debt investments to address reduced bank lending and liquidity crises.
Venture Capital Specialization
Fundrise invests in high-growth private technology companies through its Innovation Fund (VCX), which is listed on the NYSE. This fund targets mid-to-late stage companies in sectors such as AI/ML, fintech, and modern data infrastructure. Notable holdings include OpenAI, Anthropic, Databricks, and Ramp. Fundrise aims to provide individual investors access to venture capital opportunities traditionally reserved for institutional investors.
Key Differentiators
Fundrise democratizes access to private market investments (real estate, private credit, venture capital) for individual investors, traditionally reserved for institutions, with low minimums (as low as $10 for real estate and $10 for venture capital) and lower fees compared to traditional private equity funds. They leverage a proprietary technology platform for investor servicing, fund management, and asset management, replacing traditional manual processes. Fundrise also emphasizes transparency, real-time reporting, and an investor-first approach. Their venture capital arm has a deep bench of software engineers and product managers, offering a unique advantage in understanding and supporting tech companies.
Technology Stack
Fundrise has a high-performance technology platform that enables unprecedented real-time oversight and reporting. They have a large product engineering department with approximately 100 engineers, focusing on cloud data infrastructure, analytics, digital marketing, cybersecurity, payment processing, data storage, and design. They utilize AI Decisioning and reinforcement learning for personalized investor communications and to optimize content, timing, creative, and channel of messages. Their internal software systems automate back-office operations, including accounting, tax, and fund operations, processing millions of transactions and managing billions of data points. They are also exploring tokenizing their VCX fund for onchain access.
Physician Tip

For physicians looking to diversify their portfolios beyond traditional stocks and bonds, Fundrise offers accessible entry into private market alternative assets like real estate, private credit, and venture capital, historically difficult to access for individual investors. The low minimum investment requirements (as low as $10 for real estate and $10 for venture capital) make it feasible to start investing without a significant capital commitment. Fundrise's diversified funds, particularly in real estate across the Sunbelt and in high-growth tech sectors like AI/ML, can provide exposure to potentially strong long-term returns and portfolio diversification. Physicians can choose investment plans based on their objectives, such as supplemental income or long-term growth. While Fundrise aims for lower volatility than stocks and potentially higher returns than bonds, it's important to remember that private investments carry inherent risks and are less liquid than public market assets. For those with higher investment amounts (e.g., $100,000+), Fundrise offers benefits like exclusive investments and white-glove support. Fundrise also offers the option to open Traditional or Roth IRAs for tax-advantaged investing.

Fundrise's technology platform is designed for direct investor access and management of their proprietary funds. While they emphasize their internal technology stack for operations and investor personalization, there is no explicit mention of direct integrations with external financial planning software or other third-party platforms for individual investors, beyond their partnership with SoFi offering access to the Innovation Fund. However, their focus on API-driven systems suggests a potential for future integrations. Their recent partnership with xStocks to tokenize the VCX fund indicates a move towards broader interoperability within the digital asset ecosystem.

Products by Fundrise

1 product in the directory

Fundrise
Fundrise
Physician Finance & Tax
Fundrise allows physicians to passively invest in diversified private real estate portfolios with a low minimum investment, offering an alternative for wealth building and portfolio diversification.

What the Web Says

Fundrise is an online real estate investment platform that allows both accredited and non-accredited investors to access private market strategies, including real estate, private credit, and venture capital, with a low minimum investment of $10. The platform is generally praised for its user-friendly interface and accessibility, making it a popular choice for beginners looking to diversify their portfolios. However, reviews indicate mixed experiences with returns, particularly in recent years, and highlight concerns regarding liquidity and customer service.

Overall: Mixed

Strengths

  • Low minimum investment ($10), making it accessible to many investors.
  • User-friendly platform and easy-to-navigate website/app.
  • Diversification opportunities into private real estate, private credit, and venture capital.
  • Transparency in fees and investment process (though some complexity noted).
  • Potential for steady, long-term returns and passive income through dividends.
  • Open to non-accredited investors.

Limitations

  • Limited liquidity and potential penalties for early withdrawals.
  • Mixed and sometimes disappointing returns, especially in certain periods or compared to other investments like the S&P 500.
  • Customer service limitations, primarily email-based with no direct phone support.
  • Complexity of some investment details and fee structures.
  • Lack of control over individual deals and properties.
  • Concerns about management practices and potential for investor dilution raised in older reviews.

Based on reviews from: Reddit, Trustpilot, G2, YouTube, Financial Samurai, Moneywise, Finder, Business Insider, Physician on FIRE, Benzinga, Real Estate Crowdfunding Review, Jean Galea

Last updated: 2026-06-19

Videos

News, demos, and interviews about Fundrise.

Loading videos...

Videos load interactively. If none appear, search YouTube for Fundrise →

View all on YouTube

Press & Coverage

Fundrise
The Fundrise Innovation Fund (VCX) Participates in OpenAI's $122 Billion Funding Round
The Fundrise Innovation Fund (VCX) announced its participation in OpenAI's latest funding round, increasing its existing position in the AI company. OpenAI closed a new financing round of $122 billion in committed capital at a post-money valuation of $852 billion.
2026-04
Business Wire
Fundrise Innovation Fund (VCX) Announces Listing on New York Stock Exchange; Democratizing Access to Venture Capital
Fundrise announced the upcoming listing of its Fundrise Innovation Fund on the New York Stock Exchange under the ticker symbol VCX, with a target listing date of on or after March 9, 2026. This aims to give everyday investors access to private technology companies.
2026-03
Fundrise
VCX portfolio news you may have missed
Fundrise provided updates on several companies within the Innovation Fund's portfolio, including Hightouch raising $150M at a $2.75 billion valuation, Visual Layer being acquired by Camtek, and Omni raising a $120M Series C at a $1.5 billion valuation.
2026-05
Investing.com
Fundrise Innovation Fund faces steep reversal after explosive NYSE debut
The Fundrise Innovation Fund (VCX) experienced a sharp retreat in its share price after its NYSE listing, with the stock plunging 34% in one session and 31% in the previous, following a rally that saw it trade at a significant premium to its underlying value.
2026-03
Business Wire
xStocks and Fundrise Partner to Tokenize VCX Fund, Unlocking Onchain Exposure to Leading Private Tech Companies
xStocks announced a partnership with Fundrise to tokenize its Fundrise Innovation Fund (NYSE: VCX), creating a new onchain asset called VCXx. This aims to provide global investors with exposure to leading private tech companies through a tokenized asset.
2026-03
Fundrise
Shareholders approve public listing of the Innovation Fund
Fundrise announced that shareholders of the Innovation Fund overwhelmingly voted in favor of moving forward with the public listing and a six-month lockup period. The management fee adjustment measure did not pass.
2026-02
PRNewswire
Fundrise Innovation Fund (VCX) posts +68% NAV; market-price +319% after NYSE listing
The Fundrise Innovation Fund (VCX) reported a +68.39% return on net asset value for the year ended March 31, 2026, and a +319.04% market price total return from its NYSE listing date of March 19, 2026.
2026-06
SEC.gov
SEC Charges Fundrise Advisors, LLC for Paying Content Creators to Solicit Clients in Violation of the Cash Solicitation Rule
The SEC announced settled charges against Fundrise Advisors, LLC for paying over 200 social media influencers and online newsletter publishers to solicit clients from February 2016 through December 2021 without required disclosures. Fundrise agreed to a cease-and-desist order, a censure, and a $250,000 civil penalty.
2023-08

Frequently Asked Questions

Fundrise offers a variety of private market investments, including real estate (private equity and private credit) and venture capital. Their real estate offerings include diversified portfolios of residential and industrial properties, often in the Sunbelt, and private credit strategies like high-yield opportunistic bridge loan financing. For venture capital, they have the Innovation Fund (VCX), which invests in late-stage private technology companies focusing on sectors like AI/ML, modern data infrastructure, and fintech.
Fundrise Advisors LLC is an SEC-registered investment adviser. They have an Operations and Compliance team responsible for ensuring efficient execution of business processes while adhering to regulatory standards. However, it's important to note that in August 2023, Fundrise was charged by the SEC for violating cash solicitation rules by paying content creators without requiring proper disclosures to clients. Fundrise consented to a cease-and-desist order, a censure, and a $250,000 civil penalty without admitting or denying the findings.
Fundrise charges an annual advisory fee of 0.15% for its advisory services. For real estate funds (e.g., Flagship Fund, eREITs), there's an additional annual asset management fee of 0.85%. The Innovation Fund (venture capital) has a higher annual management fee of 1.85%. Fundrise aims to keep fees low by using technology and minimizing intermediaries, which they state is often lower than traditional alternative asset investment companies.
Fundrise provides customer support and investor relations, including customized real-time client performance reporting, automated dividend distribution, and automated tax management processing. They utilize technology like their internal software system, Corniceu2122, for investor servicing and fund management, and Basisu2122 for asset management and reporting across their real estate portfolio. Investors can contact their Investor Relations team via email or a contact form, with a typical response time of 1 to 2 business days.
While Fundrise focuses on direct-to-investor private market access, there's no specific information readily available about direct partnerships with healthcare systems or institutions for investment purposes. However, some companies in the healthcare navigation space, like Chapter, do partner with health systems and financial institutions to help patients navigate Medicare. Fundrise's platform is designed to provide individual investors with access to private markets that were traditionally reserved for institutional investors.
Fundrise was founded in 2012 and manages approximately $2.87 billion in equity for over 385,000 investors. They have invested over $7 billion in real estate. Fundrise is considered one of the 50 largest real estate private equity investors globally by annual deployment, deploying over $1 billion in both 2021 and 2022. Annual audited financials for their parent company, Rise Companies Corp., and material updates for their eREITs can be found on the SEC's EDGAR site.
Fundrise investments are generally intended for long-term holding, with a recommended horizon of at least five years. Private real estate and venture capital are inherently illiquid assets, meaning it can be difficult to access your capital quickly. While Fundrise reviews liquidation requests quarterly for some funds, early redemptions (before five years) may incur a 1% fee. Fundrise also reserves the right to suspend redemptions, as they did during the COVID-19 pandemic.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.